Finance Ministry presents three new investor facilitation packages to PM to boost investment climate    Egypt, Bahrain explore deeper cooperation on water resource management    Egypt condemns Israeli offensive in Gaza City, warns of grave regional consequences    Cairo University, Roche Diagnostics inaugurate automated lab at Qasr El-Ainy    Egypt expands medical, humanitarian support for Gaza patients    Egypt investigates disappearance of ancient bracelet from Egyptian Museum in Tahrir    Egypt launches international architecture academy with UNESCO, European partners    African trade ministers meet in Cairo to push forward with AfCFTA    Egypt's President, Pakistan's PM condemn Israeli attack on Qatar    Egypt signs MoUs with 3 European universities to advance architecture, urban studies    Madrid trade talks focus on TikTok as US and China seek agreement    Egypt wins Aga Khan Award for Architecture for Esna revival project    Egypt's gold prices hold steady on Sep. 15th    Egypt's Sisi, Qatar's Emir condemn Israeli strikes, call for Gaza ceasefire    Egypt condemns terrorist attack in northwest Pakistan    Egypt advances plans to upgrade historic Cairo with Azbakeya, Ataba projects    Egyptian pound ends week lower against US dollar – CBE    Egypt hosts G20 meeting for 1st time outside member states    Egypt to tighten waste rules, cut rice straw fees to curb pollution    Egypt seeks Indian expertise to boost pharmaceutical industry    Egypt prepares unified stance ahead of COP30 in Brazil    Egypt harvests 315,000 cubic metres of rainwater in Sinai as part of flash flood protection measures    Al-Sisi says any party thinking Egypt will neglect water rights is 'completely mistaken'    Egyptian, Ugandan Presidents open business forum to boost trade    Egypt's Sisi, Uganda's Museveni discuss boosting ties    Egypt's Sisi warns against unilateral Nile measures, reaffirms Egypt's water security stance    Greco-Roman rock-cut tombs unearthed in Egypt's Aswan    Egypt reveals heritage e-training portal    Sisi launches new support initiative for families of war, terrorism victims    Egypt expands e-ticketing to 110 heritage sites, adds self-service kiosks at Saqqara    Palm Hills Squash Open debuts with 48 international stars, $250,000 prize pool    On Sport to broadcast Pan Arab Golf Championship for Juniors and Ladies in Egypt    Golf Festival in Cairo to mark Arab Golf Federation's 50th anniversary    Germany among EU's priciest labour markets – official data    Paris Olympic gold '24 medals hit record value    A minute of silence for Egyptian sports    Russia says it's in sync with US, China, Pakistan on Taliban    It's a bit frustrating to draw at home: Real Madrid keeper after Villarreal game    Shoukry reviews with Guterres Egypt's efforts to achieve SDGs, promote human rights    Sudan says countries must cooperate on vaccines    Johnson & Johnson: Second shot boosts antibodies and protection against COVID-19    Egypt to tax bloggers, YouTubers    Egypt's FM asserts importance of stability in Libya, holding elections as scheduled    We mustn't lose touch: Muller after Bayern win in Bundesliga    Egypt records 36 new deaths from Covid-19, highest since mid June    Egypt sells $3 bln US-dollar dominated eurobonds    Gamal Hanafy's ceramic exhibition at Gezira Arts Centre is a must go    Italian Institute Director Davide Scalmani presents activities of the Cairo Institute for ITALIANA.IT platform    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.



Rameda starts manufacturing of generic Anviziram for COVID-19 treatment
EDA also grants approval for Rameda to begin manufacturing intravenous Remedisivir vials
Alyaa Stohy Published in Daily News Egypt on 23 - 06 - 2020

The Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents Company (Rameda) announced on Tuesday that it has started the manufacture of Anviziram.
The drug, which is the generic form of Japanese antiviral drug Avigan, contains the active pharmaceutical ingredient Favipiravir and will be used in the treatment of the novel coronavirus (COVID-19).
Avigan was developed by the Toyama Chemical Company, a subsidiary of the Japanese conglomerate Fujifilm Holdings, and contains the active ingredient Favipiravir.
The Egyptian Drug Authority (EDA) has also granted approval for Rameda to begin manufacturing of intravenous Remedisivir vials, which is also used in the treatment of coronavirus patients.
Avigan has been administered to patients with the coronavirus in clinical trials, as Favipiravir is believed to combat the virus by inhibiting viral reproduction. The trials indicate that the drug assists in stabilising viral reproduction four to six days from first use.
The Ministry of Health and Higher Education and Scientific Research have undertaken clinical trials to determine the efficacy of a range of possible treatments, including Favipiravir, on coronavirus patients.
Favipiravir has been used as experimental treatment for the virus and in clinical trials in China, Italy, Japan, and Russia. Russia's Ministry of Health has approved a generic version of the drug for use in hospitals, making Russia the first country to permit such use of Favipiravir.
"Rameda is honoured to devote its capabilities and resources to serving the Egyptian people in this unique moment," said Rameda CEO Dr Amr Morsy, "Rameda's entire production of Favipiravir is being produced under the trade name Anviziram, with capacity focused on the Egyptian market."
Morsy added that the company aims to export Anviziram to neighbouring countries upon approval from the Ministry of Health and the EDA.
In addition to Anviziram, the EDA has granted approval for Rameda to start manufacturing intravenous versions of Remedisvir, a broad-spectrum antiviral medication which has been used in coronavirus patient treatment. Rameda aims to commence production of Remdesivir in the coming period.

Clic here to read the story from its source.